What is the half-life of Cyclophosphamide (CYTOXAN) after reconstitution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 15, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the FDA Drug Label

Following IV administration, elimination half-life (t ½) ranges from 3 to 12 hours with total body clearance (CL) values of 4 to 5.6 L/h. The half-life of Cyclophosphamide (CYTOXAN) after reconstitution is not explicitly stated, but the elimination half-life after IV administration ranges from 3 to 12 hours 1.

From the Research

The half-life of cyclophosphamide after reconstitution is approximately 4.8 hours, as reported in the most relevant study 2.

Key Points to Consider

  • The stability of reconstituted cyclophosphamide is a critical factor in its efficacy and safety, with the drug degrading over time through hydrolysis.
  • Storage conditions, such as temperature, can significantly impact the stability of the solution, with higher temperatures accelerating degradation.
  • The use of glass containers instead of PVC bags is recommended to maintain stability.
  • Institutions often follow a policy of using reconstituted cyclophosphamide within 24 hours, even when refrigerated, to ensure maximum potency and patient safety.

Relevant Evidence

  • A study from 1997 2 investigated the pharmacokinetics of cyclophosphamide in patients with breast cancer, finding an elimination half-life of approximately 4.8 hours.
  • Another study from 1980 3 reported a plasma half-life of cyclophosphamide in children, ranging from 145 to 390 minutes, which is lower than values typically found in adults.
  • However, the most relevant and recent study 2 provides the most accurate estimate of the half-life of cyclophosphamide after reconstitution.

Clinical Implications

  • The relatively short half-life of cyclophosphamide after reconstitution highlights the importance of using the solution as soon as possible to ensure optimal efficacy and safety.
  • Clinicians should be aware of the potential for degradation and take steps to minimize its impact, such as storing the solution in appropriate containers and using it within the recommended timeframe.
  • By prioritizing the use of reconstituted cyclophosphamide within 24 hours, clinicians can help ensure maximum potency and patient safety.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.